Juerg Lehmann - Concepedia

Author

Juerg Lehmann

Arena Pharmaceuticals (United States)

Also Known As

J Lehmann, J. LEHMANN, J. Lehmann, Juerg Lehmann, Lehmann, J.

Publications

432

Citations

H-Index

Concepts

All Affiliations

Arena Pharmaceuticals (United States)

About

Juerg Lehmann is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	181
2	Biochemistry	4	4	120
3	Engineering	1	1	19
4	Natural Sciences	1	1	19
5	Chemical Biology	1	1	19

Juerg Lehmann

Publications

231

Citations

H-Index

Page 1

	Year	Citations
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor Daniel J. Buzard, Sun Hee Kim, Luis Lopez, ACS Medicinal Chemistry Letters ImmunologyPotent Functional AntagonistInflammationRheumatoid DisorderInflammatory Rheumatic Disease	2014	70
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile Graeme Semple, Juerg Lehmann, Amy Wong, Bioorganic & Medicinal Chemistry Letters Signal TransductionG Protein-coupled ReceptorMedicineFunctional SelectivityOrphan G-protein	2011	51
Structural basis for constitutive activity and agonist‐induced activation of the enteroendocrine fat sensor <scp>GPR</scp>119 Maja S. Engelstoft, Christoffer Norn, M. Hauge, British Journal of Pharmacology	2014	31
Tetrakis(acetoxymercuri)methane: a polymetallic reagent for labeling sulfur in nucleic acids. Kenneth G. Strothkamp, Juerg Lehmann, Stephen J. Lippard Proceedings of the National Academy of Sciences E. Coli TrnavalBiosynthesisBioorganic ChemistryEngineeringBiochemistry	1978	19
Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease Daniel J. Buzard, Sangdon Han, Luis Lopez, Bioorganic & Medicinal Chemistry Letters Clinical ImmunologyInflammationMolecular ImmunologyRobust EfficacyAutoimmune Disease	2012	18
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor Daniel J. Buzard, Thomas O. Schrader, Xiuwen Zhu, Bioorganic & Medicinal Chemistry Letters New Tricyclic IndolesBiochemistryFunctional SelectivityMedicinePotent Modulators	2014	18
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series Sangdon Han, Sanju Narayanan, Sun Hee Kim, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyHeterocyclicBiochemistryMedicinePharmacology	2015	13
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists Daniel J. Buzard, Sun Hee Kim, Juerg Lehmann, Bioorganic & Medicinal Chemistry Letters Medicinal Chemistry5-Fluoro-4,6-dialkoxypyrimidine Gpr119 AgonistsMedicineRational Drug DesignPharmacotherapy	2014	11

Page 1